Multiple Assemblies exist for SMTL entry 8cxr
Crystal structure of MraY bound to a sphaerimicin analogue; X-RAY DIFFRACTION 3.65 Å

	SMTL ID 8cxr.1 Ligands (1S,4R,5S,6R,7S,9S,10S,11S,13S,14R)-9-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]-14-(hexadecanoyloxy)-5,6,13-trihydroxy-8,16-dioxa-2,11-diazatricyclo[9.3.1.1~4,7~]hexadecane-10-carboxylic acid Polypeptides MraYAA nanobody; Phospho-N-acetylmuramoyl-pentapeptide-transferase Oligo-state hetero-1-1-mer
	SMTL ID 8cxr.2 Ligands (1S,4R,5S,6R,7S,9S,10S,11S,13S,14R)-9-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]-14-(hexadecanoyloxy)-5,6,13-trihydroxy-8,16-dioxa-2,11-diazatricyclo[9.3.1.1~4,7~]hexadecane-10-carboxylic acid Polypeptides MraYAA nanobody; Phospho-N-acetylmuramoyl-pentapeptide-transferase Oligo-state hetero-1-1-mer
	SMTL ID 8cxr.3 Ligands - Polypeptides MraYAA nanobody; Phospho-N-acetylmuramoyl-pentapeptide-transferase Oligo-state hetero-1-1-mer
	SMTL ID 8cxr.4 Ligands - Polypeptides MraYAA nanobody; Phospho-N-acetylmuramoyl-pentapeptide-transferase Oligo-state hetero-1-1-mer